Here's Why the Best Is Yet to Come for Opko Health Inc.
There's not a whole lot that looks good for Opko Health Inc. (NASDAQ: OPK) right now. The stock has dropped more than 30% so far in 2017. Several large institutional investors have reduced their positions in Opko. Although sales have risen, the company continues to lose a lot of money.
Some investors have given up entirely on Opko turning things around. However, I don't think you have to put on rose-colored glasses to see the potential long-term opportunity with the company. Here's why the best is yet to come for Opko Health.
Image source: Getty Images.
Source: Fool.com
Pfizer Inc. Aktie
26,32 €
-0,13 %
Die Community bevorzugt klar Pfizer Inc. mit vielen Buy- und nur wenigen Sell-Einschätzungen.
Das Community-Kursziel von 41 € für Pfizer Inc. deutet auf eine deutliche Steigerung um mehr als 50% gegenüber dem aktuellen Kurs von 26.32 € hin.
